Evidence map›Paper›PMID 32659175›Full record

ArticleJournal of the American College of Nutrition

Can Vitamin D and L-Cysteine Co-Supplementation Reduce 25(OH)-Vitamin D Deficiency and the Mortality Associated with COVID-19 in African Americans?

Sushil K Jain, Rajesh Parsanathan

Open access · hybridAbstract read
In one paragraph

Article in Journal of the American College of Nutrition. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 1 pooled it
5.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 1 synthesis or guideline pooled it, 46 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Vitamin D and COVID-19: where are we now?Postgraduate medicine · 2023
    Review
  9. Review
  10. N-Acetylcysteine and Other Sulfur-Donors as a Preventative and Adjunct Therapy for COVID-19.Advances in pharmacological and pharmaceutical sciences · 2022
    Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Relevance of vitamin DGene reports · 2021
    Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Sushil K JainDepartment of Pediatrics, Louisiana State University Health Sciences Center-Shreveport, Shreveport, Louisiana, USA.
Rajesh ParsanathanDepartment of Pediatrics, Louisiana State University Health Sciences Center-Shreveport, Shreveport, Louisiana, USA.ORCID 0000-0001-8973-3507
Louisiana State University Health Sciences Center Shreveport · US

Funding

Optimization of Glutathione Levels and Alzheimer Disease Risk in African AmericansR33AT010637 · NCCIH · LOUISIANA STATE UNIV HSC SHREVEPORT · PI JAIN, SUSHIL K · 2020 to 2022
$1.9M
L-cysteine, PIP3 and Insulin Signaling in DiabetesR01AT007442 · NCCIH · LOUISIANA STATE UNIV HSC SHREVEPORT · PI JAIN, SUSHIL K · 2014 to 2015
$643k
NCCIH NIH HHS R01 AT007442NCCIH NIH HHS R33 AT010637
6 · The paper itself

Abstract

Early reports indicate an association between the severity of the COVID-19 infection and the widespread 25-hydroxy vitamin D deficiency known to exist in populations around the world. Vitamin D deficiency is extremely common among African American (AA) communities, where the COVID-19 infection rate is three-fold higher, and the mortality rate nearly six-fold higher, compared with rates in predominantly white communities. COVID-19 infection primarily affects the lungs and airways. Previous reports have linked 25-hydroxy vitamin D deficiency with subclinical interstitial lung disease. AA are at risk for lower cellular glutathione (GSH) levels, and GSH deficiency epigenetically impairs VD biosynthesis pathway genes. Compared with vitamin D alone, co-supplementation of vitamin D and L-cysteine (a GSH precursor) showed a better efficacy in improving levels of GSH and VD-regulatory genes at the cellular/tissue level, increasing 25(OH) vitamin D levels, and reducing inflammation biomarkers in the blood in mice studies. We propose that randomized clinical trials are needed to examine the potential of co-supplementation with anti-inflammatory antioxidants, vitamin D and L-cysteine in correcting the 25(OH)VD deficiency and preventing the 'cytokine storm,' one of the most severe consequences of infection with COVID-19, thereby preventing the adverse clinical effects of COVID-19 infection in the vulnerable AA population.

Indexed as

Black or African AmericanCOVID-19 Drug TreatmentDietary SupplementsAnimalsAnti-Inflammatory AgentsAntioxidantsBiomarkersCOVID-19CysteineCytokinesEpigenesis, GeneticGenetic Predisposition to DiseaseGlutathioneHumansInflammationMice25-hydroxyvitamin DAnti-Inflammatory AgentsAntioxidantsBiomarkersCysteineCytokinesGlutathioneVitamin DVitaminsAfrican AmericanCOVID-19glutathioneL-cysteineVitamin D

Identifiers

PMID32659175
PMCPMC9503652
OpenAlexW3041556930

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.